189 related articles for article (PubMed ID: 9730911)
1. A dileucine sequence and an upstream glutamate residue in the intracellular carboxyl terminus of the vasopressin V2 receptor are essential for cell surface transport in COS.M6 cells.
Schülein R; Hermosilla R; Oksche A; Dehe M; Wiesner B; Krause G; Rosenthal W
Mol Pharmacol; 1998 Sep; 54(3):525-35. PubMed ID: 9730911
[TBL] [Abstract][Full Text] [Related]
2. Properties of the human arginine vasopressin V2 receptor after site-directed mutagenesis of its putative palmitoylation site.
Schülein R; Liebenhoff U; Müller H; Birnbaumer M; Rosenthal W
Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):611-6. PubMed ID: 8573100
[TBL] [Abstract][Full Text] [Related]
3. Molecular and conformational features of a transport-relevant domain in the C-terminal tail of the vasopressin V(2) receptor.
Krause G; Hermosilla R; Oksche A; Rutz C; Rosenthal W; Schülein R
Mol Pharmacol; 2000 Feb; 57(2):232-42. PubMed ID: 10648632
[TBL] [Abstract][Full Text] [Related]
4. Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.
Oksche A; Schülein R; Rutz C; Liebenhoff U; Dickson J; Müller H; Birnbaumer M; Rosenthal W
Mol Pharmacol; 1996 Oct; 50(4):820-8. PubMed ID: 8863826
[TBL] [Abstract][Full Text] [Related]
5. The role of conserved extracellular cysteine residues in vasopressin V2 receptor function and properties of two naturally occurring mutant receptors with additional extracellular cysteine residues.
Schülein R; Zühlke K; Oksche A; Hermosilla R; Furkert J; Rosenthal W
FEBS Lett; 2000 Jan; 466(1):101-6. PubMed ID: 10648821
[TBL] [Abstract][Full Text] [Related]
6. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide.
Schoneberg T; Yun J; Wenkert D; Wess J
EMBO J; 1996 Mar; 15(6):1283-91. PubMed ID: 8635461
[TBL] [Abstract][Full Text] [Related]
7. The hydrophobic amino acid residues in the membrane-proximal C tail of the G protein-coupled vasopressin V2 receptor are necessary for transport-competent receptor folding.
Thielen A; Oueslati M; Hermosilla R; Krause G; Oksche A; Rosenthal W; Schülein R
FEBS Lett; 2005 Sep; 579(23):5227-35. PubMed ID: 16162341
[TBL] [Abstract][Full Text] [Related]
8. Folding and cell surface expression of the vasopressin V2 receptor: requirement of the intracellular C-terminus.
Oksche A; Dehe M; Schülein R; Wiesner B; Rosenthal W
FEBS Lett; 1998 Mar; 424(1-2):57-62. PubMed ID: 9537515
[TBL] [Abstract][Full Text] [Related]
9. O-Glycosylation of the V2 vasopressin receptor.
Sadeghi H; Birnbaumer M
Glycobiology; 1999 Jul; 9(7):731-7. PubMed ID: 10362843
[TBL] [Abstract][Full Text] [Related]
10. Polarized expression of the vasopressin V2 receptor in Madin-Darby canine kidney cells.
Andersen-Beckh B; Dehe M; Schülein R; Wiesner B; Rutz C; Liebenhoff U; Rosenthal W; Oksche A
Kidney Int; 1999 Aug; 56(2):517-27. PubMed ID: 10432391
[TBL] [Abstract][Full Text] [Related]
11. A conserved motif for the transport of G protein-coupled receptors from the endoplasmic reticulum to the cell surface.
Duvernay MT; Zhou F; Wu G
J Biol Chem; 2004 Jul; 279(29):30741-50. PubMed ID: 15123661
[TBL] [Abstract][Full Text] [Related]
12. An X-linked NDI mutation reveals a requirement for cell surface V2R expression.
Sadeghi HM; Innamorati G; Birnbaumer M
Mol Endocrinol; 1997 Jun; 11(6):706-13. PubMed ID: 9171234
[TBL] [Abstract][Full Text] [Related]
13. Molecular aspects of vasopressin receptor function.
Schöneberg T; Kostenis E; Liu J; Gudermann T; Wess J
Adv Exp Med Biol; 1998; 449():347-58. PubMed ID: 10026824
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.
Cheong HI; Cho HY; Park HW; Ha IS; Choi Y
Nephrology (Carlton); 2007 Apr; 12(2):113-7. PubMed ID: 17371330
[TBL] [Abstract][Full Text] [Related]
15. Single amino acid substitutions and deletions that alter the G protein coupling properties of the V2 vasopressin receptor identified in yeast by receptor random mutagenesis.
Erlenbach I; Kostenis E; Schmidt C; Serradeil-Le Gal C; Raufaste D; Dumont ME; Pausch MH; Wess J
J Biol Chem; 2001 Aug; 276(31):29382-92. PubMed ID: 11375990
[TBL] [Abstract][Full Text] [Related]
16. A novel C-terminal motif is necessary for the export of the vasopressin V1b/V3 receptor to the plasma membrane.
Robert J; Clauser E; Petit PX; Ventura MA
J Biol Chem; 2005 Jan; 280(3):2300-8. PubMed ID: 15528211
[TBL] [Abstract][Full Text] [Related]
17. A serine cluster prevents recycling of the V2 vasopressin receptor.
Innamorati G; Sadeghi HM; Tran NT; Birnbaumer M
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2222-6. PubMed ID: 9482866
[TBL] [Abstract][Full Text] [Related]
18. Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function.
Zhu X; Wess J
Biochemistry; 1998 Nov; 37(45):15773-84. PubMed ID: 9843382
[TBL] [Abstract][Full Text] [Related]
19. Variant amino acids in the extracellular loops of murine and human vasopressin V2 receptors account for differences in cell surface expression and ligand affinity.
Oksche A; Leder G; Valet S; Platzer M; Hasse K; Geist S; Krause G; Rosenthal A; Rosenthal W
Mol Endocrinol; 2002 Apr; 16(4):799-813. PubMed ID: 11923476
[TBL] [Abstract][Full Text] [Related]
20. Subcellular localization and internalization of the vasopressin V1B receptor.
Kashiwazaki A; Fujiwara Y; Tsuchiya H; Sakai N; Shibata K; Koshimizu TA
Eur J Pharmacol; 2015 Oct; 765():291-9. PubMed ID: 26318147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
